Hubei Guangji Pharmaceutical Co., Ltd. (000952.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.45B
Enterprise Value2.9B
P/E Ratio-5.92
PEG Ratio0.08
Price/Sales Ratio3.47
Price/Book Ratio3.81
Enterprise/Revenue5.17
Enterprise/EBITDA-12.51

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.59
Operating Margin-0.64
AD

Management Effectiveness

Return On Assets-0.18
Return On Equity-0.54

Income Statement

Revenue623.97M
Revenue/Share1.88
Gross Profit165.8M
EBITDA-231.66M
Net Income-404.49M
Diluted EPS-1.16

Balance Sheet

Total Cash265M
Total Cash/Share0.76
Total Debt1.37B
Total Debt/Equity2.29
Current Ratio0.53
Book Value Per Share1.66

Price History

52-Week Change5.29
52-Week High10.42
52-Week Low5
Moving Average 50 Days6.25
Moving Average 200 Days6.89

Statistics

Average Volume7.45M
Shares Outstanding344M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.09
Last Split Factor6:5
Last Split DateMay 29, 2020
AD